tirzepatide/semaglutide blend Tirzepatide vs Semaglutide: What's the Difference? Concerns Surrounding Compounded GLP-1s Mount

Novo Nordisks preemptive price cut may set the stage for competitive responses from Eli Lilly, especially as Lillys tirzepatide products continue to gain share in both obesity and diabetes segments

Lancet Diabetes Endocrinol 6(4):275286 Rodbard HW, Lingvay I, Reed J, de la Rosa R, Rose L, Sugimoto D, Araki E, Chu PL, Wijayasinghe N, Norwood P (2018) Semaglutide added to basal insulin in type 2 diabetes (SUSTAIN 5): a randomized

Narrow Impact: Any benefits are limited to Medicare beneficiaries only

Purpose-built for physicians What specific risk factors do you discuss with patients who are prescribed GLP-1 agonists

A few areas to think about: Surgery How might weight loss with help from GLP1s affect surgical procedures

This necessitates regular monitoring of thyroid function during active weight loss phases to avoid overtreatment, which can cause symptoms of hyperthyroidism including palpitations, anxiety, and bone loss